Oragenics, Inc.OGENNYSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank0
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-0.7x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -73.44% |
| 2023 | 53.79% |
| 2022 | -4.85% |
| 2021 | -52.12% |
| 2020 | 82.41% |
| 2019 | 102.95% |
| 2018 | 68.72% |
| 2017 | -25.55% |
| 2016 | -45.99% |
| 2015 | 187.21% |